Induction of NADPH cytochrome P450 reductase by the Alzheimer β-protein. Amyloid as a 'foreign body'

Miguel Pappolla, Rawhi A. Omar, Yau Jan Chyan, Jorge Ghiso, Karen Hsiao, Peter Bozner, George Perry, Mark A. Smith, Felix Cruz-Sanchez

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A large body of data suggests that the Alzheimer's amyloid peptide (Aβ) causes degeneration and death of neurons by mechanisms that involve reactive oxygen species. The pathways involved in Aβ-mediated oxidative injury are only partially understood. We theorized that abnormal microaggregates and/or pathological conformations of Aβ peptides may behave as xenobiotics and trigger the induction of NADPH cytochrome P450 reductase (CP450r), an enzyme which, if induced by non-physiological substrates (such as xenobiotics like drugs or other 'foreign molecules'), is known to cause oxidative stress. In order to test this hypothesis, i.e. that Aβ can increase the expression of CP450r, SK-N-SH human neuroblastoma cells were exposed to Aβ25-35 and Aβ1-42 and then examined for induction of this enzyme in immunoblots, using specific antibodies. Following exposure to Aβ peptides, neuroblastoma cells showed a clear-cut induction of CP450r. To determine whether this mechanism is operational in vivo, we investigated the expression of CP450r in a transgenic mouse model of Alzheimer's disease (AD) and in brains from patients afflicted with AD, using an immunocytochemical approach. Tissue sections from brains of transgenic mice exhibited strong immunoreactivity for CP450r, surrounding amyloid deposits. The pattern of expression of CP450r was similar to that exhibited by neuritic and oxidative stress markers. Sections from non-transgenic mice showed no detectable immunoreactivity. Immunostaining of sections from four brains with neuropathologically confirmed AD showed a pattern of abnormality different from transgenic mice that was characterized by abnormal immunoreactivity for CP450r within the cytoplasm of cortical neurons. No labeling was seen in sections from aged-matched control brains. The data showed that CP450r is induced by Alzheimer amyloid peptide and that such a response must be considered as one possible mechanism whereby Aβ causes oxidative stress.

Original languageEnglish (US)
Pages (from-to)121-128
Number of pages8
JournalJournal of Neurochemistry
Volume78
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

NADPH-Ferrihemoprotein Reductase
Foreign Bodies
Amyloid
Oxidative stress
Brain
Proteins
Transgenic Mice
Alzheimer Disease
Oxidative Stress
Xenobiotics
Neuroblastoma
Peptides
Neurons
Nerve Degeneration
Enzyme Induction
Amyloid Plaques
Enzymes
Cytochrome P-450 Enzyme System
Labeling
Conformations

Keywords

  • Alzheimer's disease
  • Amyloid beta
  • Dementia
  • Free radicals
  • Neurotoxicity
  • Oxidative stress

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Induction of NADPH cytochrome P450 reductase by the Alzheimer β-protein. Amyloid as a 'foreign body'. / Pappolla, Miguel; Omar, Rawhi A.; Chyan, Yau Jan; Ghiso, Jorge; Hsiao, Karen; Bozner, Peter; Perry, George; Smith, Mark A.; Cruz-Sanchez, Felix.

In: Journal of Neurochemistry, Vol. 78, No. 1, 2001, p. 121-128.

Research output: Contribution to journalArticle

Pappolla, M, Omar, RA, Chyan, YJ, Ghiso, J, Hsiao, K, Bozner, P, Perry, G, Smith, MA & Cruz-Sanchez, F 2001, 'Induction of NADPH cytochrome P450 reductase by the Alzheimer β-protein. Amyloid as a 'foreign body'', Journal of Neurochemistry, vol. 78, no. 1, pp. 121-128. https://doi.org/10.1046/j.1471-4159.2001.00379.x
Pappolla, Miguel ; Omar, Rawhi A. ; Chyan, Yau Jan ; Ghiso, Jorge ; Hsiao, Karen ; Bozner, Peter ; Perry, George ; Smith, Mark A. ; Cruz-Sanchez, Felix. / Induction of NADPH cytochrome P450 reductase by the Alzheimer β-protein. Amyloid as a 'foreign body'. In: Journal of Neurochemistry. 2001 ; Vol. 78, No. 1. pp. 121-128.
@article{bca47418f9e14a87a17a7336e75b5a8c,
title = "Induction of NADPH cytochrome P450 reductase by the Alzheimer β-protein. Amyloid as a 'foreign body'",
abstract = "A large body of data suggests that the Alzheimer's amyloid peptide (Aβ) causes degeneration and death of neurons by mechanisms that involve reactive oxygen species. The pathways involved in Aβ-mediated oxidative injury are only partially understood. We theorized that abnormal microaggregates and/or pathological conformations of Aβ peptides may behave as xenobiotics and trigger the induction of NADPH cytochrome P450 reductase (CP450r), an enzyme which, if induced by non-physiological substrates (such as xenobiotics like drugs or other 'foreign molecules'), is known to cause oxidative stress. In order to test this hypothesis, i.e. that Aβ can increase the expression of CP450r, SK-N-SH human neuroblastoma cells were exposed to Aβ25-35 and Aβ1-42 and then examined for induction of this enzyme in immunoblots, using specific antibodies. Following exposure to Aβ peptides, neuroblastoma cells showed a clear-cut induction of CP450r. To determine whether this mechanism is operational in vivo, we investigated the expression of CP450r in a transgenic mouse model of Alzheimer's disease (AD) and in brains from patients afflicted with AD, using an immunocytochemical approach. Tissue sections from brains of transgenic mice exhibited strong immunoreactivity for CP450r, surrounding amyloid deposits. The pattern of expression of CP450r was similar to that exhibited by neuritic and oxidative stress markers. Sections from non-transgenic mice showed no detectable immunoreactivity. Immunostaining of sections from four brains with neuropathologically confirmed AD showed a pattern of abnormality different from transgenic mice that was characterized by abnormal immunoreactivity for CP450r within the cytoplasm of cortical neurons. No labeling was seen in sections from aged-matched control brains. The data showed that CP450r is induced by Alzheimer amyloid peptide and that such a response must be considered as one possible mechanism whereby Aβ causes oxidative stress.",
keywords = "Alzheimer's disease, Amyloid beta, Dementia, Free radicals, Neurotoxicity, Oxidative stress",
author = "Miguel Pappolla and Omar, {Rawhi A.} and Chyan, {Yau Jan} and Jorge Ghiso and Karen Hsiao and Peter Bozner and George Perry and Smith, {Mark A.} and Felix Cruz-Sanchez",
year = "2001",
doi = "10.1046/j.1471-4159.2001.00379.x",
language = "English (US)",
volume = "78",
pages = "121--128",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Induction of NADPH cytochrome P450 reductase by the Alzheimer β-protein. Amyloid as a 'foreign body'

AU - Pappolla, Miguel

AU - Omar, Rawhi A.

AU - Chyan, Yau Jan

AU - Ghiso, Jorge

AU - Hsiao, Karen

AU - Bozner, Peter

AU - Perry, George

AU - Smith, Mark A.

AU - Cruz-Sanchez, Felix

PY - 2001

Y1 - 2001

N2 - A large body of data suggests that the Alzheimer's amyloid peptide (Aβ) causes degeneration and death of neurons by mechanisms that involve reactive oxygen species. The pathways involved in Aβ-mediated oxidative injury are only partially understood. We theorized that abnormal microaggregates and/or pathological conformations of Aβ peptides may behave as xenobiotics and trigger the induction of NADPH cytochrome P450 reductase (CP450r), an enzyme which, if induced by non-physiological substrates (such as xenobiotics like drugs or other 'foreign molecules'), is known to cause oxidative stress. In order to test this hypothesis, i.e. that Aβ can increase the expression of CP450r, SK-N-SH human neuroblastoma cells were exposed to Aβ25-35 and Aβ1-42 and then examined for induction of this enzyme in immunoblots, using specific antibodies. Following exposure to Aβ peptides, neuroblastoma cells showed a clear-cut induction of CP450r. To determine whether this mechanism is operational in vivo, we investigated the expression of CP450r in a transgenic mouse model of Alzheimer's disease (AD) and in brains from patients afflicted with AD, using an immunocytochemical approach. Tissue sections from brains of transgenic mice exhibited strong immunoreactivity for CP450r, surrounding amyloid deposits. The pattern of expression of CP450r was similar to that exhibited by neuritic and oxidative stress markers. Sections from non-transgenic mice showed no detectable immunoreactivity. Immunostaining of sections from four brains with neuropathologically confirmed AD showed a pattern of abnormality different from transgenic mice that was characterized by abnormal immunoreactivity for CP450r within the cytoplasm of cortical neurons. No labeling was seen in sections from aged-matched control brains. The data showed that CP450r is induced by Alzheimer amyloid peptide and that such a response must be considered as one possible mechanism whereby Aβ causes oxidative stress.

AB - A large body of data suggests that the Alzheimer's amyloid peptide (Aβ) causes degeneration and death of neurons by mechanisms that involve reactive oxygen species. The pathways involved in Aβ-mediated oxidative injury are only partially understood. We theorized that abnormal microaggregates and/or pathological conformations of Aβ peptides may behave as xenobiotics and trigger the induction of NADPH cytochrome P450 reductase (CP450r), an enzyme which, if induced by non-physiological substrates (such as xenobiotics like drugs or other 'foreign molecules'), is known to cause oxidative stress. In order to test this hypothesis, i.e. that Aβ can increase the expression of CP450r, SK-N-SH human neuroblastoma cells were exposed to Aβ25-35 and Aβ1-42 and then examined for induction of this enzyme in immunoblots, using specific antibodies. Following exposure to Aβ peptides, neuroblastoma cells showed a clear-cut induction of CP450r. To determine whether this mechanism is operational in vivo, we investigated the expression of CP450r in a transgenic mouse model of Alzheimer's disease (AD) and in brains from patients afflicted with AD, using an immunocytochemical approach. Tissue sections from brains of transgenic mice exhibited strong immunoreactivity for CP450r, surrounding amyloid deposits. The pattern of expression of CP450r was similar to that exhibited by neuritic and oxidative stress markers. Sections from non-transgenic mice showed no detectable immunoreactivity. Immunostaining of sections from four brains with neuropathologically confirmed AD showed a pattern of abnormality different from transgenic mice that was characterized by abnormal immunoreactivity for CP450r within the cytoplasm of cortical neurons. No labeling was seen in sections from aged-matched control brains. The data showed that CP450r is induced by Alzheimer amyloid peptide and that such a response must be considered as one possible mechanism whereby Aβ causes oxidative stress.

KW - Alzheimer's disease

KW - Amyloid beta

KW - Dementia

KW - Free radicals

KW - Neurotoxicity

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=0034932917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034932917&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.2001.00379.x

DO - 10.1046/j.1471-4159.2001.00379.x

M3 - Article

VL - 78

SP - 121

EP - 128

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -